Trypanocidal activity of diarylheptanoids from Schrankia leptocarpa DC  by Lagnika, L. et al.
Available online at www.sciencedirect.com
South African Journal of Botany 83 (2012) 92–97
www.elsevier.com/locate/sajbTrypanocidal activity of diarylheptanoids from Schrankia leptocarpa DC
L. Lagnika a,⁎, B. Weniger b, B. Attioua c, O. Jensen d, C. Anthaume b, A. Sanni a, M. Kaiser e,
A. Lobstein b, C. Vonthron-Senecheau b
a Laboratoire de Biochimie et de Biologie Moléculaire, Département de Biochimie et de Biologie Cellulaire, Université d'Abomey-Calavi, 04 BP 0320 Cotonou,
Benin
b Laboratoire de Pharmacognosie et Molécules Naturelles Bioactives, Faculté de Pharmacie, Université de Strasbourg, UMR CNRS-UdS 7200, France
c Laboratoire de Chimie Organique Biologique, UFR Sciences des Structures de la Matière et de la Technologie, Université de Cocody, Abidjan, Côte D'Ivoire
d Laboratoire de Pharmacognosie, Université de Liège CHU - B36 - Tour 4 Av. de l'hôpital, 14000 Liège, Belgique
e Swiss Tropical and Public Health Institution, Socinstrasse 57, 4002 Basel, Switzerland, University of Basel, Basel, Switzerland
Received 17 March 2012; received in revised form 22 June 2012; accepted 24 June 2012
Available online 28 August 2012Abstract
Schrankia leptocarpa is a medicinal species use traditionally in Benin to treat malaria. A previous study showed interesting antimalarial activity
against two strains of Plasmodium falciparum. Phytochemical investigation of S. leptocarpa DC. (Mimosaceae) led to the isolation of two
diarylheptanoids (1–2), three phenolic acid (3–5), one p-coumaric acid derivate (6) and three ﬂavonoids (7–9). The structures of the isolated
compounds were established by combination of spectroscopic methods. All isolated compounds were tested in vitro for antiprotozoal activity
against P. falciparum, Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania donovani. Compounds 1 and 2 showed trypanocydal
and antiplasmodial activities in the micromolar range. Compound 1 showed also strong submicromolar trypanocidal activity against T. b.
rhodensiense with an IC50 value of=0.79±0.3 μM.
© 2012 SAAB. Published by Elsevier B.V. All rights reserved.
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Schrankia leptocarpa DC. (Mimosaceae) is a straggling
perennial herb native of tropical South America and introduced
into West Africa, where the species are traditionally used in folk
medicine. In Benin, the aerial part is used in decoction to treat
eruptive fevers and hypertension (Adjanohoun et al., 1989).
Alkaloids have been described in the fruit of the close related
species Schrankia uncinata (Smolenski et al., 1973). No
phytochemical studies have been reported to date on this species.⁎ Corresponding author. Tel.: +229 97604889.
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http://dx.doi.org/10.1016/j.sajb.2012.06.011Actually, malaria is the most crucial problem of public
health in African sub-Saharan countries. 74% of the population
lives in area of strong endemic disease and 18% in epidemic
area. About 600 million persons are exposed to malaria, and
because of the devastating nature of the illness and the failure of the
most affordable therapeutic agents there is an urgent need to
develop new drugs or vaccines for the treatment, prevention and
management of the disease (Asase et al., 2010;Waako et al., 2005).
Human African trypanosomiasis (HTA) is a parasitic disease
which affects humans and animals, caused by protozoa of the
species Trypanosoma brucei and transmitted by the tsetse fly.
The disease is endemic in some regions of sub-Saharan Africa,
covering about 36 countries and 60 million people. About
48,000 people died of it in 2008 (Boseley, 2009). The treatment
and control of the disease was based on the prophylactic ands reserved.
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over decades leads to drug resistance which grows to a major
problem (Peregrine, 1994).
The increasing global spread of drug resistance to most of the
available and affordable antiprotozoal drugs is a major concern and
requires innovative strategies to combat the disease. There is an
urgent need for new chemotherapeutic compounds, which are easy
to administer and store, and which are of low cost (Asokan et al.,
2011).
In a continuing search for antiprotozoal compounds from
traditionally used medicinal plants, we have previously investi-
gated a crude methanolic extract of the aerial part of S. leptocarpa
which was found to be active in vitro against Plasmodium
falciparum K1 multidrug resistant strain (Weniger et al., 2004).
In this study, we report the isolation and structure elucidation
of two diarylheptanoids (1–2), three phenolic acid (3–5), one
p-coumaric acid derivate (6) and three flavonoids (7–9). All
isolated compounds were evaluated for their in vitro antiprotozoal
activities against human pathogens responsible of malaria, visceral
leishmaniasis, Chaga's disease and sleeping sickness.
2. Materials and methods
2.1. Plant material
Entire plant of S. leptocarpaDC. (Mimosaceae) was collected
in October 2008 in the area of Sèmè-Kpodji, Ouémé department
(Southern Benin). Botanical identification of the plant was
performed by taxonomists from the Herbier National of
Abomey-Calavi University in Benin. A voucher specimen
(Houngnon 954b) was deposited at the same Herbarium. The
collected entire plant was air-dried, powdered, and subjected
to extraction with methanol.
2.2. Extraction and isolation
Dry powdered aerial parts of S. leptocarpa (750 g) were
extracted with 2 L methanol using a Soxhlet extractor. The
methanolic extract was taken to dryness under vacuum,
yielding 75.6 g. It was afterwards dissolved in water (750 ml)
and then partitioned with cyclohexane (250 ml x 4), methylene
chloride (400 ml x 3), ethyl acetate (400 ml x 3) and methanol
(400 ml x 3). Each extract was taken to dryness under vacuum
and the residues were stored at room temperature. The methylene
chloride was purified on column chromatography (Si gel 60,
0.063–0.200; Merk) using a mixture of increasing solvent
polarity (methylene chloride, ethyl acetate and finally methanol)
to obtain three subfractions named Sbf1, Sbf2 and Sbf3. The
sub-fractions Sbf2 and Sbf3 obtained were purified again by
preparative liquid chromatography (Gilson VP 250/21, Nucléodur
100–10 C18ec, Macherey Nagel, UV detection 205 nm) by
gradient elution (flow rate 10 ml/min) using water–methanol
(50:50 to 100:00 v/v) with 0.01% formic acid as mobile phase, to
obtain compounds 1 (17.2 mg) and 2 (8.7 mg).
The ethyl acetate extract (2.5 g) was dissolved in methanol and
purified by preparative liquid chromatography (Gilson VP 250/21,
Nucléodur 100–10 C18ec, Macherey Nagel, UV detection254 nm) by gradient elution (flow rate 10 ml/min) using acidified
water (0.01% formic acid) and methanol (80:20 to 00:100 v/v) as
mobile phase, to obtain compounds 3 (18.2 mg), 4 (23.4 mg) and
5 (8 mg).
The methanol extract (10 g) was first cleaned using Sephadex
LH-20 exclusion chromatography (Sephadex LH20, 25–100 μm,
Merck), according to the method described by Houghton and
Raman (1998). To remove tannins, the methanol extract was first
dissolved in 100 ml of methanol/water (1:1, v/v) and 50 ml of
methylene chloride are added to the obtained mixture. After
homogenization, two phases (liquid and precipitate) are formed.
The mobile phase was concentrated and cleaned using Sephadex
LH-20 column (diameter: 3 cm; Sephadex height: 35 cm) and the
mixture of methanol and methylene chloride (80:20, v/v) as mobile
phase. The tannin free methanol extract was afterwards purified
using preparative liquid chromatography (Gilson VP 250/21,
Nucléodur 100–10 C18ec, Macherey Nagel, UV detection
280 nm) by gradient elution (flow rate 10 ml/min) using acidified
water (0.01% formic acid) and methanol (95:05 to 00:100 v/v,
65 min) as mobile phase to obtain twelve (12) fractions among
which four correspond to compounds 6 (9.5 mg), 7 (29.3 mg),
8 (6.2 mg) and 9 (9.7 mg).
Structural determination of the isolated compounds was carried
out by spectrophotometric methods. NMR spectra (1D and 2D)
were recorded inMeOH-d4 using a Bruker 400Mhz spectrometer.
The chemical shifts (δ) are reported in parts per million (ppm)
relative to tetramethylsilane (TMS δ=0). The coupling constants
(J) are given in Hz. COSY, HSQC and HMBC experiments were
recorded with gradient enhancements using sine-shaped gradient
pulses. The raw data were transformed and the spectra evaluated
with the standard Bruker NMRtec NMRnotebook software. FT-IR
experiment was achieved with, SmartOrbit ATR, Thermo Nicollet
380 (Thermo Electron Corporation). LC/HR-ESI-MS, were
recorded on a HPLC Agilent 1200RRLC equipped with an
Agilent 6520 AccurateMass Q-TOF spectrometer, HPLCwas also
used for UV spectra. TheMass spectra ESI-MSwere recordedwith
a spectrometer. The nine isolated compounds were identified by
comparing their spectroscopic data with those of reported values.
Our spectroscopic data were in accordance with the published data
in the literature.
2.3. Biological assays
2.3.1. Antiplasmodial activity
Antiplasmodial activity was evaluated against the 3D7 sensitive
strain and the K1 resistant strain of P. falciparum. Quantitative
assessment of in vitro antimalarial activity against the Kl resistant
strain was determined by means of the microculture radioisotope
technique based on the method previously described by Desjardins
et al. (1979) and modified by Ridley et al. (1996). The assay uses
the uptake of [3H]hypoxanthine by parasites as an indicator of
viability. Continuous in vitro cultures of asexual erythrocytic
stages of P. falciparum were maintained following the methods of
Trager and Jensen (1976). Compounds were tested against Kl
strain (multidrug pyrimethamine/chloroquine resistant strain)
(Thaithong and Beale, 1981). Initial concentration of each
compound was 30 μg/ml diluted with two-fold dilutions to make
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incubation of the parasites with the compound at 37 °C, [3H]
hypoxanthine (Amersham 115 Int., Buckinghamshire, UK) was
added to each well and the incubation was continued for another
24 h at the same temperature. IC50 was calculated by linear
interpolation between the two drug concentrations above and
below 50% (Huber and Koella, 1993). Chloroquine and
artemisinin were used as positive references. The values are
means of two independent assays. Each assay was run in
duplicate.
Continuous cultures of asexual erythrocytic stages of an 3D7
chloroquine sensitive strain of P. falciparum were maintained
following the procedure of Trager and Jensen (1976) and as
described previously (Frederich et al., 2002). Parasite growth was
estimated by determination of lactate dehydrogenase activity as
described by Delhaes et al. (1999) and Makler et al. (1993) and
slightly modified. Briefly, in a new microtiter plate, a 20 μl
subsample of the contents of each well was mixed with 100 μl of a
substrate solution containing 1 mg lithium L-lactate (Sigma),
0.2 mg 3-acetyl pyridine adenine dinucleotide (APAD, Sigma),
0.2 μl Triton X-100 (Sigma), 10 μg saponine (Merck) in TRIS
buffer (pH 8, Sigma). After incubation for 20 min, 20 μl of a mix
of nitroblue tetrazolium (NBT, 2 mg/ml in TRIS pH 8 buffer,
SIGMA) and phenazine ethosulfate (PES, 0.1 mg/ml in TRIS pH
8 buffer, Sigma) was added to each well. After another 30 min of
incubation, the formation of the reduced form of APAD was
measured at 595 nm. Each test sample was applied in a series of
eight fourfold dilutions (final concentrations ranging from 20 to
0.0012 μg/ml) and was tested in triplicate. Artemisinin (Sigma,
Bornem, Belgium) and chloroquine diphosphate (Sigma C6628),
were used as antimalarial references.
2.3.2. Antitrypanosomal activity
The assays were performed according to the procedures
described by Freiburghaus et al. (1996). The compounds were
dissolved in 10% DMSO, and working stock solutions of 1 mg/
mL in serum containing culture medium were prepared. Diluted
compounds (100 μL) were pipetted in duplicate into the first
row of a 96-well microtiter plate (Costar, Corning, NY, USA).
With complete culture medium, three-fold serial dilutions were
prepared. After the addition of Trypanosoma brucei rhodesiense
bloodstream form trypanosomes from axenic culture, the concen-
trations of the compounds ranged from 500 to 0.07 μg/mL. The
total number of trypanosomes in eachwell was 2×102/100 μl. The
plate was then incubated for 72 h at 37 °C in 5% CO2. Two hours
before the end of the incubation 10 μl of Alamar blue solution was
added. Fluorescence was measured after 2 h of incubation with the
dye Alamar blue in a fluorescence plate reader at 530 nm
excitation and 590-nm emission wavelength (Cytofluor 2300,
Millipore, Bedford, MA, USA) (Räz et al., 1997). IC50 values
were calculated from the sigmoidal inhibition curve. The
values are means of two independent assays. Each assay was
run in duplicate.
2.3.3. Trypanosoma cruzi assay
Rat skeletal myoblasts (L-6 cells) were seeded in 96-well
microtiter plates at 2000 cells per well per 100 μL in RPMI1640 medium with 10% FBS and 2 mM glutamine. After 24 h,
5000 trypomastigotes of T. cruziwere added in each well (100 μL)
with or without a serial drug dilution. The plates were incubated at
37 °C in 5% CO2 for 4 days. After 96 h, the minimum inhibitory
concentration (MIC) was determined microscopically. For mea-
surement of the IC50, the substrate CPRG/Nonidet was added to the
wells. The color reaction that developed during the following
2–4 h was read photometrically at 540 min. IC50 values were
calculated from the sigmoidal inhibition curve. The values are
means of two independent assays. Each assay was run in triplicate.
2.3.4. Leishmanicidal activity
Fifty microliters of culture medium, a 1:1 mixture of SM
medium (Cunningham, 1977) and SDM-79 medium (Brun and
Schönenberger, 1979) at pH 5.4 supplemented with 10%
heat-inactivated FBS, was added to each well of a 96-well
microtiter plate (Costar). Serial drug dilutions in duplicates were
prepared covering a range from 30 to 0.041 μg/mL. Then, 105
axenically grown Leishmania donovani amastigotes (strain
MHOM/ET/67/L82) in 50 μL medium were added to each well
and the plate incubated at 37 °C under a 5% CO2 atmosphere for
72 h. Ten microliters of resazurin solution (12.5 mg resazurin
dissolved in 100 mL distilled water) were then added to each well
and incubation continued for a further 2–4 h. The plate was then
read in a Spectramax Gemini XS microplate fluorometer
(Molecular Devices, Sunnyvale, CA, USA) using an excitation
wavelength of 536 nm and emission wavelength of 588 nm
(Räz et al., 1997). Fluorescence development was measured
and expressed as percentage of the control. Data were
transferred into the graphic program Softmax Pro (Molecular
Devices), which calculated IC50 values. The values are means
of two independent assays. Each assay was run in triplicate.
3. Results and discussion
The phytochemical analysis of the aerial parts of S.
leptocarpa led to the isolation of nine (9) compounds
identified as 1,7-bis-(4-hydroxyphenyl)-3-hepten-5-one (1),
5-hydroxy-1,7-bis(4-hydroxyphenyl)heptan-3-one (2), Methyl
-1-chlorogenate (3), Ethyl-1-chlorogenate (4), Caffeic acid (5),
p-coumarylagmatine (6), Quercetin 3-rhamnosyl-(1–2)
[rhamnosyl-(1–6)-glucoside or Manghasline (7), Kaempferol
3-(2,6-dirhamnosylglucoside) or Mauritianin (8) and Quer-
cetin 3-neohesperidoside (9) (see Fig. 1).
Compound 1 was previously isolated from Betula platyphylla
var. japonica (Fuchino et al., 1996) and Alnus maximowiczii
(Motoo et al., 1995), 2 from Alpinia officinarum (Matsuda et al.,
2009) and Alpinia blepharocalyx (Ali et al., 2001), 3, 4, and 5
identified from Eremochloa ophiuroides and Helianthus annuus
(Lee et al., 2010; Hiroshi and Shingo, 1972), 6 from Hordeum
vulgare and barley (Lee et al., 1997; Stoess, 1965). The three
flavonoids (7–9) were also previously isolated. Compound 7
from Vasconcellea pubescens and Styphnolobium japonicum
(Simirgiotis et al., 2009; Kite et al., 2007), 8 from Acalypha
indica (Nahrstedt et al., 2006) and 9 from Ficus pumila
(Abraham et al., 2008). To the best of our knowledge,
compounds 1–9 are described for the first time from this genus.
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Fig. 1. Isolated compounds from S. leptocarpa.
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activities against P. falciparum Kl multidrug-resistant strain, P.
falciparum 3D7 chloroquine-sensitive strain, T. b. rhodesienseSTIB 900 strain, T. cruzi Tulahuen C4 strain, and L. donovani
MHOM-ET-67/L82 strain (Table 1). The most active compounds
were the two isolated diarylheptanoids (1–2), the three phenolic
Table 1
Inhibitory effect of compounds isolated from S. leptocarpa.
Compounds Antiprotozoal activity IC50 (μM)
T.b. rhodensiense T. cruzi L. donovani P. falciparum
K1 3D7
1 0.79±0.17 27.67±3.18 9.27±1.78 7.93±1.34 18.14±1.65
2 7.03±1.43 78.41±6.94 51.88±13.49 7.73±0.40 37.52±1.34
3 N90 N90 N90 N5 N50
4 31.47±2.12 N90 N90 N5 N50
5 34.65±0.37 N90 N90 N5 N50
Control
Melarsoprol 0.005
Benznidazole 1.69
Miltefosine 0.47
Chloroquine 0.19 0.039
artemisinin 0.007 –
Data shown are values from duplicate experiments.
P. falciparum K1 resistant strain; P. falciparum 3D7 sensitive strain; L. donovani MHOM/ET/67/L82 strain axenic amastigotes; T. brucei rhodesiense STIB 900
strain trypomastigotes; T. cruzi Tulahuen C4 strain.
96 L. Lagnika et al. / South African Journal of Botany 83 (2012) 92–97acids derivatives showing no to weak activity (IC50N10 μM).
1–2 showed trypanocidal and antiplasmodial activities in the
sub-micromolar to themicromolar ranges against T. b. rhodesiense
(0.79±0.17 μM and 7.03±1.43 μM) and P. falciparum K1
multiresistant strain (7.93±1.34 and 7.73±0.4 μM). The most
active compound being 1 (IC50=0.79±0.17 μM).
Previous work showed antileishmanial (Alves et al., 2003;
Araujo et al., 1998) and antitrypanosome (Kamnaing et al., 2003)
activities for diarylheptanoids. Our results are in accordance with
those obtained previously and provide scientific evidence
supporting the use of S. leptocarpa in folk medicine.
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